Osprey Medical, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2005-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://ospreymed.com
DyeVert™ System for Contrast Monitoring in At-Risk Patients Undergoing Angiography: A Real-World Registry
- Conditions
- Patients at Risk for Developing Contrast-induced Nephropathy
- First Posted Date
- 2019-01-31
- Last Posted Date
- 2022-04-18
- Lead Sponsor
- Osprey Medical, Inc
- Target Recruit Count
- 10000
- Registration Number
- NCT03825094
- Locations
- 🇺🇸
Hartford Healthcare, Hartford, Connecticut, United States
🇺🇸Steward Palmetto General Hospital, Hialeah, Florida, United States
🇺🇸Emory Healthcare, Atlanta, Georgia, United States
DyeVert™ Plus Contrast Reduction System Multicenter Observational Study
- Conditions
- Chronic Kidney Disease
- First Posted Date
- 2018-10-23
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Osprey Medical, Inc
- Target Recruit Count
- 114
- Registration Number
- NCT03715452
- Locations
- 🇺🇸
Harbor UCLA Medical Center, Torrance, California, United States
🇺🇸Atlanta VA Medical Center, Emory University School of Medicine, Atlanta, Georgia, United States
🇺🇸University of Chicago Medical Center, Chicago, Illinois, United States
DyeVert System RCT
- Conditions
- Coronary Angiography
- First Posted Date
- 2016-04-27
- Last Posted Date
- 2017-02-28
- Lead Sponsor
- Osprey Medical, Inc
- Target Recruit Count
- 96
- Registration Number
- NCT02752802
- Locations
- 🇩🇪
University Hospital of Schleswig-Holstein, Lübeck, Germany
DyeVert Pilot Trial
- Conditions
- Coronary Angiography
- First Posted Date
- 2015-11-17
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- Osprey Medical, Inc
- Target Recruit Count
- 44
- Registration Number
- NCT02606734
- Locations
- 🇦🇺
Monash Health, Clayton, Victoria, Australia
🇩🇪University Hospital of Schleswig-Holstein, Lübeck, Germany
AVERT Plus Post-Market Registry
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2015-05-07
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- Osprey Medical, Inc
- Target Recruit Count
- 20
- Registration Number
- NCT02436642
- Locations
- 🇩🇪
Universitatsklinikum Schleswig-Holstein (Campus Lubeck), Lubeck, Germany
Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients
- Conditions
- DiabetesInfection
- Interventions
- Procedure: Percutaneous Isolated Limb Perfusion (PILP) delivery
- First Posted Date
- 2014-06-06
- Last Posted Date
- 2016-09-30
- Lead Sponsor
- Osprey Medical, Inc
- Target Recruit Count
- 15
- Registration Number
- NCT02158442
- Locations
- 🇦🇺
Royal Melbourne Hospital, Parkville, Victoria, Australia
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
- Conditions
- Contrast Induced Nephropathy (CIN)
- First Posted Date
- 2013-11-05
- Last Posted Date
- 2017-02-28
- Lead Sponsor
- Osprey Medical, Inc
- Target Recruit Count
- 578
- Registration Number
- NCT01976299
- Locations
- 🇺🇸
UCSD Medical Center, La Jolla, California, United States
🇺🇸Long Beach CA VA Hospital, Long Beach, California, United States
🇺🇸Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States
Contrast Media Reduction and Removal in Patients With Chronic Kidney Disease (CKD) (PRESERV)
- Conditions
- Radiographic Contrast Agent Nephropathy
- First Posted Date
- 2010-07-22
- Last Posted Date
- 2016-12-12
- Lead Sponsor
- Osprey Medical, Inc
- Target Recruit Count
- 16
- Registration Number
- NCT01168024
- Locations
- 🇺🇸
Heart Care Research, LLC, Huntsville, Alabama, United States
🇺🇸St. Luke's Medical Center, Phoenix, Arizona, United States
🇺🇸Kaiser Permanente, Los Angeles, California, United States